Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0165
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT

Emmaus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
116138260
Upgrade
Market Cap Growth
-91.23%-91.23%-52.02%-84.34%36.67%-36.90%
Upgrade
Enterprise Value
3332394210342
Upgrade
Last Close Price
0.020.010.100.261.671.23
Upgrade
PE Ratio
-----44.50
Upgrade
Forward PE
---4.34--
Upgrade
PS Ratio
0.060.030.210.704.002.60
Upgrade
PB Ratio
-0.02-0.01-0.13-0.38-3.84-11.68
Upgrade
EV/Sales Ratio
1.961.911.312.274.991.82
Upgrade
EV/EBITDA Ratio
--10.85--1503.76
Upgrade
EV/EBIT Ratio
--10.95---
Upgrade
Debt / Equity Ratio
-0.58-0.58-0.70-0.90-1.04-3.68
Upgrade
Debt / EBITDA Ratio
--7.05--15.45
Upgrade
Asset Turnover
0.570.570.710.350.360.39
Upgrade
Inventory Turnover
0.720.720.660.760.580.30
Upgrade
Quick Ratio
0.060.060.130.040.090.12
Upgrade
Current Ratio
0.110.110.190.120.250.48
Upgrade
Return on Assets (ROA)
-4.03%-4.03%5.31%-7.84%-6.59%-0.03%
Upgrade
Return on Capital (ROIC)
-----51.80%-0.18%
Upgrade
Earnings Yield
-612.37%-1188.71%-60.31%-82.36%-19.36%2.25%
Upgrade
FCF Yield
-218.07%-423.32%-24.56%-39.53%-1.61%-4.09%
Upgrade
Buyback Yield / Dilution
-19.07%-19.07%-7.41%-0.38%-0.73%-15.71%
Upgrade
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.